Chiltern Expands European Operations with a New Office in The Netherlands
pharmafile | March 29, 2011 | News story | Research and Development |
Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO) announced that it has opened a new office in the Netherlands, appointing Angela Pasma as the Netherlands’ Country Manager.
Mr. Maurizio Passanisi, Chiltern’s Director of the Benelux Region commented, “The
Netherlands continues to be an excellent place for clinical research with experienced
investigators as well as highly regarded international key opinion leaders, all adhering to the highest of medical standards.
“Furthermore, in leading the growth of the Chiltern office in Leiden, Ms. Pasma brings a
wealth of knowledge and experience to support Chiltern’s growing full service clinical and flexible staffing services in the region.”
Pasma added, “Having already cultivated positive relationships with clients and colleagues in the region, we look forward to expanding our operations here to further serve our clients’ needs. The Leiden office is well situated geographically to support this effort.”
Armand Czaplinski, Executive Director, Global Country Management for Chiltern, further
explained, “Chiltern’s expansion in the Netherlands aligns perfectly with our primary goal to deliver expert, high quality services around the world and demonstrates our ongoing
commitment to regional expansion in order to serve our clients’ needs globally.”






